353 related articles for article (PubMed ID: 1463271)
21. Influence of dopamine on the altered release of prolactin, luteinizing hormone, and follicle-stimulating hormone induced by interleukin-2 in vitro.
Karanth S; Marubayashi U; McCann SM
Neuroendocrinology; 1992 Dec; 56(6):871-80. PubMed ID: 1369597
[TBL] [Abstract][Full Text] [Related]
22. The effect of interleukin-2 on the release of gonadotropin and prolactin in vivo and in vitro.
Umeuchi M; Makino T; Arisawa M; Izumi S; Saito S; Nozawa S
Endocr J; 1994 Oct; 41(5):547-51. PubMed ID: 7889115
[TBL] [Abstract][Full Text] [Related]
23. Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats.
McDonald JK; Lumpkin MD; Samson WK; McCann SM
Proc Natl Acad Sci U S A; 1985 Jan; 82(2):561-4. PubMed ID: 3855566
[TBL] [Abstract][Full Text] [Related]
24. Atrial natriuretic factor inhibits luteinizing hormone secretion in the rat: evidence for a hypothalamic site of action.
Samson WK; Aguila MC; Bianchi R
Endocrinology; 1988 Apr; 122(4):1573-82. PubMed ID: 2964365
[TBL] [Abstract][Full Text] [Related]
25. Desensitization of the dopaminergic inhibition of pituitary luteinizing hormone release by prolactin in ovariectomized rats.
Beck W; Wuttke W
J Endocrinol; 1977 Jul; 74(1):67-74. PubMed ID: 874418
[TBL] [Abstract][Full Text] [Related]
26. Role of laminin on prolactin and gonadotrophin release from anterior pituitaries of male rats.
Denduchis B; Rettori V; McCann SM
Life Sci; 1994; 55(22):1757-65. PubMed ID: 7968255
[TBL] [Abstract][Full Text] [Related]
27. Dose-dependent inhibition of the preovulatory surges of gonadotropins and prolactin by the antiestrogen CI-628: possible sites of action.
De Paolo LV
Biol Reprod; 1985 May; 32(4):745-52. PubMed ID: 3924129
[TBL] [Abstract][Full Text] [Related]
28. Involvement of preoptic-anterior hypothalamic GABA neurons in the regulation of pituitary LH and prolactin release.
Lamberts R; Vijayan E; Graf M; Mansky T; Wuttke W
Exp Brain Res; 1983; 52(3):356-62. PubMed ID: 6653697
[TBL] [Abstract][Full Text] [Related]
29. Atrazine disrupts the hypothalamic control of pituitary-ovarian function.
Cooper RL; Stoker TE; Tyrey L; Goldman JM; McElroy WK
Toxicol Sci; 2000 Feb; 53(2):297-307. PubMed ID: 10696778
[TBL] [Abstract][Full Text] [Related]
30. Neurotensin-induced activation of hypothalamic dopaminergic neurons is accompanied by a decrease in pituitary secretion of prolactin and alpha-melanocyte-stimulating hormone.
Pan JT; Tian Y; Lookingland KJ; Moore KE
Life Sci; 1992; 50(25):2011-7. PubMed ID: 1593929
[TBL] [Abstract][Full Text] [Related]
31. Immunoreactive neurotensin in gonadotrophs and thyrotrophs is regulated by sex steroid hormones in the female rat.
Bello AR; Hernández G; González M; Reyes R; Negrín I; Marrero A; Sánchez-Criado JE; Tramu G; Alonso R
J Neuroendocrinol; 1999 Oct; 11(10):785-94. PubMed ID: 10520127
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 1 alpha inhibits prostaglandin E2 release to suppress pulsatile release of luteinizing hormone but not follicle-stimulating hormone.
Rettori V; Gimeno MF; Karara A; Gonzalez MC; McCann SM
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2763-7. PubMed ID: 1901415
[TBL] [Abstract][Full Text] [Related]
33. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion.
Samson WK; Keown C; Samson CK; Samson HW; Lane B; Baker JR; Taylor MM
Endocrine; 2003; 20(1-2):59-66. PubMed ID: 12668869
[TBL] [Abstract][Full Text] [Related]
34. Effects of hyperprolactinemia on the control of luteinizing hormone and follicle-stimulating hormone secretion in the male rat.
Smith MS; Bartke A
Biol Reprod; 1987 Feb; 36(1):138-47. PubMed ID: 3105612
[TBL] [Abstract][Full Text] [Related]
35. Melanin-concentrating hormone stimulates the release of luteinizing hormone-releasing hormone and gonadotropins in the female rat acting at both median eminence and pituitary levels.
Chiocchio SR; Gallardo MG; Louzan P; Gutnisky V; Tramezzani JH
Biol Reprod; 2001 May; 64(5):1466-72. PubMed ID: 11319153
[TBL] [Abstract][Full Text] [Related]
36. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
[TBL] [Abstract][Full Text] [Related]
37. Role of nitric oxide in control of prolactin release by the adenohypophysis.
Duvilanski BH; Zambruno C; Seilicovich A; Pisera D; Lasaga M; Diaz MC; Belova N; Rettori V; McCann SM
Proc Natl Acad Sci U S A; 1995 Jan; 92(1):170-4. PubMed ID: 7529411
[TBL] [Abstract][Full Text] [Related]
38. The effect of neurotensin on pituitary secretion of thyrotrophin and prolactin in vitro.
Askew RD; Ramsden DB; Sheppard MC
Acta Endocrinol (Copenh); 1984 Feb; 105(2):156-60. PubMed ID: 6695547
[TBL] [Abstract][Full Text] [Related]
39. Altered gonadotropin and prolactin release induced by median eminence (ME) lesions and pharmacological manipulation of prolactin release: further evidence for separate hypothalamic control of FSH and LH release.
Marubayashi U; McCann SM; Antunes-Rodrigues J
Brain Res Bull; 1989 Sep; 23(3):193-200. PubMed ID: 2510908
[TBL] [Abstract][Full Text] [Related]
40. Acute inhibition of PRL and TSH secretion after intraventricular injection of PRL in ovariectomized rats.
Mangat HK; McCann SM
Am J Physiol; 1983 Jan; 244(1):E31-6. PubMed ID: 6849381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
